Leveraging Nuclear Receptors as Targets for Pathological Ocular Vascular Diseases

Leveraging Nuclear Receptors as Targets for Pathological Ocular Vascular Diseases

Vasculogenesis and angiogenesis are physiological mechanisms occurring throughout the body. Any disruption to the precise balance of blood vessel growth necessary to support healthy tissue, and the inhibition of abnormal vessel sprouting has the potential to negatively impact stages of development a...

Full description

Bibliographic Details
Main Authors:	Pei-Li Yao, Jeremy Peavey, Goldis Malek
Format:	Article
Language:	English
Published:	MDPI AG 2020-04-01
Series:	International Journal of Molecular Sciences
Subjects:	nuclear receptors angiogenesis wet age-related macular degeneration proliferative diabetic retinopathy inflammation
Online Access:	https://www.mdpi.com/1422-0067/21/8/2889

Similar Items

Nuclear Receptor Atlases of Choroidal Tissues Reveal Candidate Receptors Associated with Age-Related Macular Degeneration
by: Jeremy Peavey, et al.
Published: (2022-08-01)

A comparative debate on the various anti-vascular endothelial growth factor drugs: Pegaptanib sodium (Macugen), ranibizumab (Lucentis) and bevacizumab (Avastin)
by: Nagpal Manish, et al.
Published: (2007-01-01)

Retinopathy Phenotypes in Type 2 Diabetes with Different Risks for Macular Edema and Proliferative Retinopathy
by: Ines P. Marques, et al.
Published: (2020-05-01)

Research progress of circular RNAs in ocular proliferative diseases
by: Tian-Jing Yang, et al.
Published: (2021-06-01)

Vitreous Humor Proteome: Targeting Oxidative Stress, Inflammation, and Neurodegeneration in Vitreoretinal Diseases
by: Fátima Milhano Santos, et al.
Published: (2022-03-01)

Ocular Vascular Diseases: From Retinal Immune Privilege to Inflammation
by: Xudong Wang, et al.
Published: (2023-07-01)

Frequency of diabetic retinopathy in patients with diabetes mellitus and its correlation with duration of diabetes mellitus
by: Piyush Bansal, et al.
Published: (2013-01-01)

Correlation between responses to intravitreal injection of anti-VEGF and diabetic retinopathy extent in diabetic macular edema patients
by: Yue Huang, et al.
Published: (2017-02-01)

Comparison of choroidal thickness in normal eyes and different ocular pathologies in a Brazilian population
by: Murilo U. Polizelli, et al.
Published: (2020-08-01)

Bevacizumab for ocular neovascular diseases: a systematic review
by: Regis Bruni Andriolo, et al.

Mitochondrial Heme Synthesis Enzymes as Therapeutic Targets in Vascular Diseases
by: Trupti Shetty, et al.
Published: (2020-07-01)

Different Mechanisms Causing Macular Hole Development in Proliferative Diabetic Retinopathy
by: Sinan Tatlıpınar
Published: (2012-05-01)

Editorial: Ocular neurodegenerative diseases: novel mechanisms, diagnosis, and therapeutic strategies
by: Wenyi Wu, et al.
Published: (2023-09-01)

Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial
by: Luca Filippi, et al.
Published: (2017-07-01)

Nogo-B Promotes Angiogenesis in Proliferative Diabetic Retinopathy via VEGF/PI3K/Akt Pathway in an Autocrine Manner
by: Yuelu Zhang, et al.
Published: (2017-10-01)

Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
by: Yu-jie Li, et al.
Published: (2015-03-01)

Diverse roles of macrophages in intraocular neovascular diseases: a review
by: Ye-Di Zhou, et al.
Published: (2017-12-01)

Progress of the application of Conbercept in ocular neovascular diseases
by: Xiao-Dong Chen, et al.
Published: (2022-08-01)

Research progress on the role of gut microbiota in ocular diseases
by: Jia-Yi Jiang, et al.
Published: (2023-07-01)

Early multifocal electroretinography findings after intravitreal Conbercept in the treatment of wet age-related macular degeneration
by: Ding-Guo Huang, et al.
Published: (2018-09-01)

Correlations Between Different Angiogenic and Inflammatory Factors in Vitreous Fluid of Eyes With Proliferative Diabetic Retinopathy
by: Guanrong Wu, et al.
Published: (2021-09-01)

Research progress on the roles of transforming growth factor-β in proliferative retinal diseases
by: Xiao-Dong Li, et al.
Published: (2022-12-01)

Propranolol: a new pharmacologic approach to counter retinopathy of prematurity progression
by: Francesca Pascarella, et al.
Published: (2024-01-01)

Association of Age and Sex with Different Status of Serum Vitamin D Level among Different Grades of Diabetic Retinopathy: A Cross-sectional Study
by: Rajarshi As, et al.
Published: (2022-04-01)

Emerging roles of circular RNAs in retinal diseases
by: Aneliya Hanineva, et al.
Published: (2022-01-01)

Oxidative stress and epigenetics in ocular vascular aging: an updated review
by: Bowen Zhao, et al.
Published: (2023-02-01)

Ferrochelatase is a therapeutic target for ocular neovascularization
by: Halesha D Basavarajappa, et al.
Published: (2017-06-01)

High-Density Lipoprotein Cholesterol in Age-Related Ocular Diseases
by: Bjorn Kaijun Betzler, et al.
Published: (2020-04-01)

Age-Related Macular Degeneration Revisited: From Pathology and Cellular Stress to Potential Therapies
by: Majda Hadziahmetovic, et al.
Published: (2021-01-01)

Kinins and Their Receptors as Potential Therapeutic Targets in Retinal Pathologies
by: Rahmeh Othman, et al.
Published: (2021-07-01)

Advances of metabolomics in ocular diseases
by: Jiang Jiaxuan, et al.
Published: (2024-03-01)

Role of mitophagy in ocular neurodegeneration
by: Calvin D. Brooks, et al.
Published: (2023-10-01)

miR-145, miR-92a and miR-375 Show Differential Expression in Serum from Patients with Diabetic Retinopathies
by: Adriana Solis-Vivanco, et al.
Published: (2022-09-01)

Ocular macrophage origin and heterogeneity during steady state and experimental choroidal neovascularization
by: Steven Droho, et al.
Published: (2020-11-01)

Regulation of epithelial-mesenchymal transition in retinal pigment epithelium and its associated cellular signaling cascades: an updated review
by: Brijesh Gelat, et al.
Published: (2023-10-01)

Proteomics profiling of vitreous humor reveals complement and coagulation components, adhesion factors, and neurodegeneration markers as discriminatory biomarkers of vitreoretinal eye diseases
by: Fátima M. Santos, et al.
Published: (2023-02-01)

Metabolomics and Biomarkers in Retinal and Choroidal Vascular Diseases
by: Xiao-Wen Hou, et al.
Published: (2022-08-01)

Macular edema in siliconized eyes
by: Kaya A, et al.
Published: (2016-05-01)

Refractive Outcome in Preterm Newborns With ROP After Propranolol Treatment. A Retrospective Observational Cohort Study
by: Luca Filippi, et al.
Published: (2019-11-01)

Propranolol 0.2% Eye Micro-Drops for Retinopathy of Prematurity: A Prospective Phase IIB Study
by: Luca Filippi, et al.
Published: (2019-05-01)